Amikacin

Amikacin is a powerful antibiotic medicine. It's used to treat serious infections caused by certain bacteria. Like other antibiotics, it works by killing the germs that are making you sick. It's important to take it exactly as your doctor tells you to, as it can have side effects.

Brand names:Amikin
Medication

What people taking Amikacin report

Every report comes from a Lived member, sent anonymously.

Have you tried Amikacin for Mycobacterium avium-intracellulare Infection?

NameHow it went

About Amikacin

What It's For

Amikacin is a powerful antibiotic from the aminoglycoside family, a group of drugs reserved mainly for serious bacterial infections. It comes in two very different forms used for different purposes. Amikacin injection, given into a vein or a muscle, is a hospital antibiotic for serious infections caused by bacteria such as Pseudomonas, E. coli and Klebsiella. These include bloodstream infections (including in newborns), pneumonia, meningitis, and infections of the bones, joints, skin, abdomen and urinary tract, as well as infected burns and wounds after surgery. It is especially useful when bacteria have become resistant to related antibiotics such as gentamicin or tobramycin. Because of its side effects, it is not used for a simple first bladder infection unless gentler antibiotics will not work. Arikayce is an inhaled form of amikacin for adults with Mycobacterium avium complex (MAC) lung disease, a slow, stubborn infection caused by bacteria related to those that cause tuberculosis. It is reserved for people whose sputum (mucus coughed up from the lungs) still grows MAC after at least six months of standard multidrug treatment, and it is added to that regimen rather than replacing it.

How It Works

Bacteria need a constant supply of new proteins to survive and multiply. Amikacin attaches to the bacterial ribosome, the structure that builds those proteins, and disrupts it, which kills the bacteria rather than simply slowing them down. Its chemical structure resists several of the enzymes bacteria use to disable related aminoglycosides, which is why it can still work when gentamicin or tobramycin no longer does. It is often combined with another antibiotic, such as a penicillin-type drug, to cover more kinds of bacteria. Arikayce packages amikacin inside tiny fat bubbles called liposomes. Breathed in as a mist, these deliver the drug into the lungs, where MAC lives, while keeping the amount that reaches the rest of the body relatively low.

Dosage & Administration

Injected amikacin is given by a nurse, either as an infusion into a vein or as a shot into a muscle, on a schedule set by the care team. The dose is calculated from body weight and kidney function, because the kidneys clear the drug from the body. The team usually checks blood levels of amikacin to make sure the dose is high enough to work but not so high that it causes harm. A typical course lasts 7 to 10 days, and longer courses call for closer monitoring. Arikayce is taken at home once a day by inhaling the contents of one vial through a dedicated nebulizer, the Lamira Nebulizer System; it should not be used with any other device. People with asthma, chronic obstructive pulmonary disease (COPD) or airways prone to spasm may be told to use their rescue inhaler first. If a dose is missed, the next one is taken the following day; doses are not doubled.

Side Effects

The most important risk of injected amikacin is damage to the inner ear and the kidneys. Ear damage can affect hearing, usually starting with high-pitched sounds that a person may not notice until a hearing test picks them up, or balance, causing dizziness or unsteadiness. This hearing loss is usually permanent and can develop or worsen even after treatment ends. Kidney injury shows up first in blood tests and is usually reversible once the drug is stopped. Both risks rise with higher doses, longer courses, existing kidney problems, existing hearing or balance problems, older age and dehydration, which is why kidney function, drug levels and sometimes hearing are checked during treatment. Ringing or roaring in the ears, dizziness, vertigo or any change in hearing should be reported to the care team promptly, since the drug may need to be adjusted or stopped. Less often, amikacin can cause numbness, tingling or muscle twitching. With Arikayce, the most common problems come from inhaling it: hoarseness, cough, throat irritation and wheezing, along with tiredness, diarrhea, nausea and headache. Inhaled amikacin can also affect hearing and balance: in the main trial, ringing in the ears and dizziness were more common in people taking Arikayce than in those who were not, and these symptoms should be reported to the care team. Arikayce carries a boxed warning, the most prominent warning the US Food and Drug Administration (FDA) requires, because it increases the risk of serious breathing problems: airway spasm (wheezing or chest tightness), coughing up blood, an allergic-type lung inflammation called hypersensitivity pneumonitis, and flare-ups of the underlying lung disease. Some of these have led to hospital stays, and many people in the trials stopped the drug because of side effects. New or worsening shortness of breath, wheezing or coughing up blood should be reported to the care team right away. Swelling of the face or throat or severe trouble breathing after a dose may be anaphylaxis, a severe allergic reaction, and needs emergency care by calling 911. Like other antibiotics, amikacin can lead to a C. difficile gut infection. Watery or bloody diarrhea, even weeks after treatment, is worth a prompt call to the care team.

Interactions & Warnings

Amikacin should not be used by people who have had an allergic reaction to it, and Arikayce should not be used after an allergic reaction to any aminoglycoside. The injection also contains a sulfite preservative, which can trigger allergic-type or asthma reactions in people sensitive to sulfites. The main interaction concern is stacking drugs that strain the same organs. Other aminoglycosides, vancomycin (an antibiotic), amphotericin B (an antifungal), cisplatin (a chemotherapy drug), and colistin or polymyxin B (last-resort antibiotics) can add to kidney or ear damage, as can strong diuretics (water pills) such as furosemide (Lasix). When these combinations cannot be avoided, monitoring becomes more intensive. Aminoglycosides can weaken the signal between nerves and muscles. This rarely matters on its own but can cause dangerous muscle weakness or breathing difficulty in people with myasthenia gravis (an autoimmune condition that weakens muscles) or around anesthesia and surgery, so the anesthesia team should know about amikacin. Some people carry an inherited change in their mitochondrial DNA (the MT-RNR1 gene) that makes aminoglycoside hearing loss much more likely, even at normal drug levels. A family history of hearing loss after these antibiotics is worth mentioning before treatment. Aminoglycosides cross the placenta and can cause permanent deafness in a developing baby. Anyone who is pregnant or could become pregnant should discuss the risks and alternatives, although in a life-threatening infection the benefit may outweigh this risk.

What to Expect

In a hospital, amikacin is usually one part of a broader treatment plan. People with straightforward infections often start to improve within one to two days. If there is no clear improvement within three to five days, the team typically rechecks which bacteria are involved and whether they are susceptible, or looks for an abscess that needs draining. Regular blood tests track kidney function and drug levels, and people on longer courses or at higher risk may have hearing tests before, during and after treatment. Arikayce is a longer commitment. It was approved on an accelerated basis because, in a clinical trial, adding it to standard treatment helped significantly more people clear MAC from their sputum cultures by six months. It has not yet been shown to improve breathing, walking distance or quality of life, and its continued approval depends on further trials confirming a real clinical benefit. People taking it give regular sputum samples to see whether the infection is clearing, and in the main trial, people whose cultures cleared kept taking it for 12 months after their first negative culture. Hoarseness and cough are common, especially early on, and the care team can help decide whether the side effects are manageable or whether stopping makes more sense.

Questions to Ask Your Doctor

  1. 1.Why is amikacin the right antibiotic for my infection, and are there less toxic options that would work?
  2. 2.How will my kidneys, drug levels and hearing be monitored, and should I have a hearing test before starting?
  3. 3.Do any of my other medicines, such as water pills or other antibiotics, raise my risk of side effects?
  4. 4.For Arikayce, how will we know if it is working, and how long would I stay on it?
  5. 5.What should I do if I notice ringing in my ears, dizziness or breathing problems?

Last reviewed • Oct 2026

Educational content, not medical advice.